Parse Biosciences raises $41.5M to scale Evercode single-cell RNA sequencing kits that profile up to 1M cells

Parse Biosciences, a Seattle startup co-founded by CEO Alex Rosenberg and CTO Charles Roco, raised $41.5 million to expand its single-cell RNA sequencing kits and software, which scale to profile up to one million cells using standard lab equipment. The company, launched from University of Washington research, now has more than 300 customers and emphasizes ease of use versus competitors requiring specialized hardware.

AAlex Rosenberg PParse Biosciences SSplit Biosciences